INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Pooled results from many studies on one question.

364 studies · page 16 of 16

1998 / Systematic review and meta-analysis of controlled trials

Hypoallergenic formula substitution and reduced stimulation help alleviate infantile colic

A systematic review examined 27 controlled trials testing dietary, drug, and behavioral interventions for infantile colic in infants under 6 months old. Replacing cow's milk protein with hypoallergenic formula was effective (effect size 0.22, 95% CI 0.09 to 0.34), as was advising carers to reduce stimulation (effect size 0.48, 95% CI 0.23 to 0.74). Soy and low-lactose formulas showed unclear results.

Lucassen PL, Assendelft WJ, Gubbels JW, et al. BMJ, 1998. PMID 9596593

1997 / Meta-analysis of dietary intervention studies

Adhering to dietary recommendations reduces plasma total and LDL cholesterol by roughly 5% compared with the average American diet.

A meta-analysis analyzed 224 intervention studies published between 1966 and 1994, encompassing 8,143 subjects and 878 diet-blood lipid comparisons, using weighted multiple-regression analysis. Regression models for total cholesterol, triacylglycerol, LDL, HDL, and VLDL cholesterol showed multiple correlations of 0.74, 0.65, 0.41, 0.14, and 0.34, respectively. Study characteristics, initial intakes, and baseline concentrations had little effect on these models. Predictions indicated that following recommendations of 30% energy from fat, <10% saturated fat, and <300 mg cholesterol/day will lower plasma total and LDL-cholesterol by approximately 5% compared to an average American diet.

Howell WH, McNamara DJ, Tosca MA, et al. Am J Clin Nutr, 1997. PMID 9174470

1996 / Meta-analysis of 10 randomized controlled trials

In a meta-analysis, patients with recent-onset IDDM given nicotinamide had significantly higher baseline C-peptide at one year than controls.

A meta-analysis evaluated 10 randomized controlled trials (5 placebo-controlled) comprising 211 nicotinamide-treated patients with recent-onset IDDM. One year after diagnosis, baseline C-peptide was significantly higher in nicotinamide-treated patients than in control patients (0.73 +/- 0.65 vs. 0.32 +/- 0.56 ng/ml, P < 0.005), which remained significant when analyzing only the placebo-controlled trials (P < 0.05). No differences were found between groups for insulin dose or glycosylated hemoglobin. Adverse effects reported among 291 patients receiving nicotinamide were transient transaminase elevation (n = 2), skin rash (n = 2), and recurrent hypoglycemia (n = 2).

Pozzilli P, Browne PD, Kolb H Diabetes Care, 1996. PMID 8941464

1992 / Meta-analysis of controlled trials

A mathematical model showed good fit relating baseline and added dietary cholesterol to serum levels.

Researchers analyzed 76 data points from 27 controlled feeding trials supplying diets through metabolic kitchens. A nonlinear regression model accounting for baseline intake alongside added dietary cholesterol yielded a good fit to serum cholesterol changes (P < 0.0005, r = 0.617 between observed and predicted values). The mathematical equation described a hyperbolic shape for the relationship between added intake and serum cholesterol response.

Hopkins PN Am J Clin Nutr, 1992. PMID 1534437